Guidance

UK-wide licensing for human medicines

Information on the implementation of changes to the licensing of medicines for human use in the UK following the agreement of the Windsor Framework.

Documents

Details

This guidance is designed to provide information on the implementation of changes to the licensing of medicines for human use in the UK following the agreement of the Windsor Framework.

Published 29 September 2023